Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Clinical Infectious Diseases2005Vol. 40(11), pp. 1625–1634
Citations Over TimeTop 1% of 2005 papers
P. Munoz, Emilio Bouza, M. Cuenca-Estrella, José Marı́a Eiros Bouza, María Jesús Pérez-Granda, M. Sánchez-Somolinos, C. Rincon, Javier Hortal, Teresa Peláez
Abstract
Use of S. cerevisiae probiotics should be carefully reassessed, particularly in immunosuppressed or critically ill patients.
Related Papers
- → Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements(2021)52 cited
- → Saccharomyces Cerevisiae Fungemia, a Possible Consequence of the Treatment of Clostridium Difficile Colitis with a Probioticum(2014)49 cited
- → Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use(2016)41 cited
- → The Effect of the Yeast Probiotic Saccharomyces boulardii on Acute Diarrhea in Children(2021)6 cited
- → The Victorian Medical Show(2010)